HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LU 51198

highly sulfated, low molecular weight heparin

Also Known As:

LU-51198; LU51198

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - Glycosaminoglycans: 5640
    - Heparin: 24996
      - LU 51198: 1

Experts

1.	Birck, Rainer: 1 article (06/2007)
2.	Braun, Claude: 1 article (06/2007)
3.	Gottmann, Uwe: 1 article (06/2007)
4.	Mueller-Falcke, Astrid: 1 article (06/2007)
5.	Nickeleit, Volker: 1 article (06/2007)
6.	Schnuelle, Peter: 1 article (06/2007)
7.	Yard, Benito A: 1 article (06/2007)
8.	van der Woude, Fokko J: 1 article (06/2007)

Related Diseases

1.	Ischemia 06/01/2007 - "The aim of the study was to evaluate the effect of the hypersulfated nonanticoagulant heparin derivative LU 51198 (LU) and of the low molecular weight heparin reviparin (REVI) on ischemia/reperfusion (I/R) injury, acute rejection (AR) and chronic allograft nephropathy (CAN) in rats. "

Related Drugs and Biologics

1.	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
2.	Heparin (Liquaemin)
3.	reviparin (reviparin-sodium)